Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Director/PDMR Shareholding

14 Mar 2023 16:16

RNS Number : 9601S
Tyman PLC
14 March 2023
Β 

TYMAN PLC

("Tyman" or the "Company" or the "Group")

Β 

DIRECTOR/PDMR SHAREHOLDINGS

Β 

Tyman plc announces that it has been notified of the following transactions in the Company's ordinary 5p shares ("Ordinary Shares") undertaken by the Executive Directors and PDMRs, Jo Hallas, CEO and Jason Ashton, CFO.

Β 

DEFERRED SHARE BONUS PLAN (THE "DSBP")

Β 

On 10 March 2023 the following shares were awarded in respect of the year ended31 December 2022 (the "2022 Awards") under the Company's DSBP, in the form of nil cost options.

Name

Shares awarded1

Jo Hallas

36,875

Jason Ashton

19,245

1 Number of shares calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 9th March 2023) of Β£2.461.

Β 

Under the Company's annual bonus scheme, 50% of Executive Director bonuses that would otherwise have been payable in cash are instead delivered as deferred shares under the DSBP.

Β 

These awards will normally vest (together with dividend equivalents in cash or Ordinary Shares) following the publication of the Group's audited results for the year ending31 December 2025, expected to be in March 2026. No consideration was paid for the 2022 Awards and no consideration is due to be payable on vesting.

Β 

LONG TERM INCENTIVE PLAN (THE "LTIP")

On 10 March 2023 ("Award Date"), the following shares were awarded under the Company's LTIP, in the form of nil cost options (the "2023 Awards"):

Name

Shares awarded1

Jo Hallas

351,991

Jason Ashton

183,705

1 Number of shares calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 9th March 2023) of Β£2.461.

Β 

Performance conditions

Β 

The vesting of the 2023 Awards is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company, as disclosed in the 2022 Annual Report and Accounts, to be published on 3 April 2023. Awards granted to the Executive Directors that vest shall be subject to a compulsory holding period of five years from the Award Date.

Β 

2023 Awards are expected to vest in March 2026, following the announcement of the Company's results for the year ended 31 December 2025, subject to fulfilment of the performance conditions and continued employment in the Group, and the holding requirement is expected to expire in March 2028.

Β 

Timetable and Awards Outstanding

Β 

The details of the Awards are set out below:

1

Β 

Details of the persons discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Names

Β 

i. JO HALLAS

ii. JASON ASHTON

Β 

2

Β 

Reason for the notification:Β AWARD OF OPTIONS

Β 

a)

Β 

Position/status

Β 

i. CHIEF EXECUTIVE OFFICER

ii. CHIEF FINANCIAL OFFICER

Β 

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

TYMAN PLC

b)

Β 

LEI

Β 

213800AAFUV5PKGQU848

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

Β 

Identification code

ISIN NUMBER:GB00B29H4253

b)

Β 

Nature of the transaction

NIL COST OPTIONS GRANTED UNDER TYMAN PLC DEFERRED SHARE BONUS PLAN

c)

Prices (s) and volume(s)

Price

Volume

i.

Nil

36,875

ii.

Nil

19,245

d)

Β 

Aggregated information

- Aggregated volume

- 56,120

Β 

- Price

- Nil

e)

Β 

Date of the transaction

Β 

10 March 2023

f)

Β 

Place of the transaction

OUTSIDE OF TRADING VENUE

1

Β 

Details of the persons discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Names

Β 

i. JO HALLAS

ii. JASON ASHTON

Β 

2

Β 

Reason for the notification:Β AWARD OF OPTIONS

Β 

a)

Β 

Position/status

Β 

i. CHIEF EXECUTIVE OFFICER

ii. CHIEF FINANCIAL OFFICER

Β 

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

TYMAN PLC

b)

Β 

LEI

Β 

213800AAFUV5PKGQU848

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

Β 

Identification code

ISIN NUMBER:GB00B29H4253

b)

Β 

Nature of the transaction

NIL COST OPTIONS GRANTED SUBJECT TO PERFORMANCE CONDITIONS UNDER TYMAN PLC LONG TERM INCENTIVE PLAN

c)

Prices (s) and volume(s)

Price

Volume

i.

Nil

351,991

ii.

Nil

183,705

d)

Β 

Aggregated information

- Aggregated volume

- 535,696

Β 

- Price

- Nil

e)

Β 

Date of the transaction

Β 

10 March 2023

f)

Β 

Place of the transaction

OUTSIDE OF TRADING VENUE

Β 

This disclosure is made in accordance with Article 19 of EU Market Abuse Regulation No. 596/2014Β as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

Β 

Β 

Β 

14 March 2023

Β 

Β 

Β 

Enquiries:

Tyman plc

020 7976 8000

Peter Ho - General Counsel & Company Secretary

www.tymanplc.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHQZLFFXXLFBBX
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.